| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |